Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285527 · ClinicalTrials.gov registry record · NA
MiSight 1 Day Safety Post-Approval Study
A NA study of Myopia, sponsored by CooperVision.
- Recruiting
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
- 20
- Study locations
NCT05285527 is a NA study of Myopia that is actively recruiting participants, run by CooperVision. The registered enrollment target is 2,400 participants, above the 241-participant average among 90 other Myopia trials with a reported enrollment target (896% higher). The trial reports 20 study locations across 7 states.
The verdict
NCT05285527, a NA study of Myopia, is actively recruiting participants, sponsored by CooperVision.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.
Conditions Studied
Interventions
- DEVICE MiSight 1 Day
Study Locations (20)
California
- University of California, Berkeley University Eye Center - Berkeley
- Golden Vision Cupertino Optometry - Cupertino
- Boghossian Vision - Danville
- Iron Horse Optometric Group - Dublin
- Capitol Eye Care Center Optometry - Fremont
- Irvine Eye Physicians and Surgeons Inc - Irvine
- Elsa Pao OD, Inc - Oakland
- Perfect Pair Optometry - San Jose
- Almaden Family Optometric Center - San Jose
Florida
- Planet Vision Eyecare - Lake Worth
- Marino Eye Care - Miami
- Vision Source Oviedo, INC - Oviedo
- Dau Family Eye Care - Saint Johns
- Gulf Coast Eye Center - Sarasota
- Weston Contact Lens Institute LLC - Weston
Arizona
- Experts on Sight LLC. - Gilbert
Arkansas
- Centerton Family Eyecare - Centerton
Colorado
- Children's Eye Physicians - Centennial
Connecticut
- Eye Physicians & Surgeons, PC - Milford
Illinois
- Lurie Childrens - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2027-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05285527
The ClinicalTrials.gov registry entry for NCT05285527 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 241-participant average among 90 other Myopia trials with a reported enrollment target (896% higher). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which MiSight 1 Day is the first listed.
NCT05285527 reports 20 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Arizona.
Frequently Asked Questions
What is clinical trial NCT05285527 about?
NCT05285527 is a clinical study titled "MiSight 1 Day Safety Post-Approval Study". The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.
What is the current status of trial NCT05285527?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,400 participants. The study started on 2022-08-15. Estimated completion is 2027-05-30.
What conditions does trial NCT05285527 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT05285527?
The interventions under investigation include: MiSight 1 Day (DEVICE).
Who is sponsoring clinical trial NCT05285527?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05285527 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.